These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 15605777

  • 1. [Role of taxanes in treatment of breast cancer].
    Gorbunova VA, Besova NS.
    Vopr Onkol; 2004; 50(4):492-500. PubMed ID: 15605777
    [No Abstract] [Full Text] [Related]

  • 2. [Breast cancer: HER2 changes one's cards on the table].
    Lopez M.
    Clin Ter; 2005; 156(5):255-62. PubMed ID: 16382976
    [Abstract] [Full Text] [Related]

  • 3. Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients.
    Vici P, Viola G, Botti C, Rossi S, Vitucci C, Corsetti S, Di Lauro L, Sergi D, Foggi P, Perri P, Tirelli C, Mottolese M, Fattoruso SI, Lopez M.
    Clin Ter; 2008; 159(6):449-52. PubMed ID: 19169607
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. HER2-positive breast cancer: update on Breast Cancer International Research Group trials.
    Nabholtz JM, Reese DM, Lindsay MA, Riva A.
    Clin Breast Cancer; 2002 Oct; 3 Suppl 2():S75-9. PubMed ID: 12435291
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
    Roddiger SJ, Kolotas C, Filipowicz I, Kurek R, Kuner RP, Martin T, Baltas D, Rogge B, Kontova M, Hoffmann G, Pollow B, Zamboglou N.
    Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Current data concerning neoadjuvant chemotherapy].
    Depierre A.
    Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S11-3. PubMed ID: 16719148
    [No Abstract] [Full Text] [Related]

  • 11. [Docetaxel (Taxotere) in combination with anthracycline, capecitabin (Xeloda) and new drugs].
    Galligioni E.
    Tumori; 2001 Feb; 87(1 Suppl 2):S1-9. PubMed ID: 11357871
    [No Abstract] [Full Text] [Related]

  • 12. The expanding role of epirubicin in the treatment of breast cancer.
    Glück S.
    Cancer Control; 2002 Feb; 9(2 Suppl):16-27. PubMed ID: 11965227
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
    Sparano JA.
    Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
    [Abstract] [Full Text] [Related]

  • 17. [Optimal role of docetaxel in adjuvant chemotherapy for early stage HER2-negative breast cancer].
    Fattoruso SI, Rossi S, Vici P, Di Filippo F, Botti C, Di Lauro L, Foggi P, Saracca E, Ferranti FR, Visca P, Lopez M.
    Clin Ter; 2008 Apr; 159(6):443-7. PubMed ID: 19169606
    [Abstract] [Full Text] [Related]

  • 18. [Docetaxel (Taxotere) in combination with trastuzumab (Herceptin)].
    Ficorella C.
    Tumori; 2001 Apr; 87(1 Suppl 2):S10-8. PubMed ID: 11357872
    [No Abstract] [Full Text] [Related]

  • 19. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
    Hudis CA, Seidman AD, Baselga J, Raptis G, Lebwohl D, Gilewski T, Currie V, Moynahan ME, Sklarin N, Fennelly D.
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
    [Abstract] [Full Text] [Related]

  • 20. Are anthracycline-taxane regimens the new standard of care in the treatment of metastatic breast cancer?
    Valero V, Hortobagyi GN.
    J Clin Oncol; 2003 Mar 15; 21(6):959-62. PubMed ID: 12637456
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.